Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment

被引：5

作者：

Athyros, VG

Papageorgiou, AA

Symeonidis, AN

Elisaf, M

机构：

[1] Atherosclerosis Res Unit, Thessaloniki 55132, Greece

[2] Aristotle Univ Thessaloniki, Hippokratio Gen Hosp, Propedeut Dept Internal Med 2, GR-55132 Thessaloniki, Greece

[3] Greek Society Gen Practitioners, Thessaloniki 54625, Greece

[4] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece

来源：

ATHEROSCLEROSIS | 2003年 / 168卷 / 02期

关键词：

D O I：

10.1016/S0021-9150(03)00128-X

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：397 / 398

页数：2

共 7 条

[1]

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].

Athyros, VG ;

Papageorgiou, AA ;

Mercouris, BR ;

Athyrou, VV ;

Symeonidis, AN ;

Basayannis, EO ;

Demitriadis, DS ;

Kontopoulos, AG .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228

[2]

Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) [J].

Bittner, V ;

Hardison, R ;

Kelsey, SF ;

Weiner, BH ;

Jacobs, AK ;

Sopko, G .

CIRCULATION, 2002, 106 (20) :2537-2542

[3]

Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[4]

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality [J].

Cui, YD ;

Blumenthal, RS ;

Flaws, JA ;

Whiteman, MK ;

Langenberg, P ;

Bachorik, PS ;

Bush, TL .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) :1413-1419

[5]

Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy [J].

Frost, PH ;

Havel, RJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :26B-31B

[6]

Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes - The Strong Heart Study [J].

Lu, WQ ;

Resnick, HE ;

Jablonski, KA ;

Jones, KL ;

Jain, AK ;

Howard, WJ ;

Robbins, DC ;

Howard, BV .

DIABETES CARE, 2003, 26 (01) :16-23

[7]

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study [J].

Pedersen, TR ;

Olsson, AG ;

Færgeman, O ;

Kjekshus, J ;

Wedel, H ;

Berg, K ;

Wilhelmsen, L ;

Haghfelt, T ;

Thorgeirsson, G ;

Pyörälä, K ;

Miettinen, T ;

Christophersen, B ;

Tobert, JA ;

Musliner, TA ;

Cook, TJ .

CIRCULATION, 1998, 97 (15) :1453-1460

← 1 →